Jordan's Pharma launches Center of Excellence as an "open platform"

9 April 2006

At the end of last month, the Jordanian Association of Pharmaceutical Manufacturers held a press conference to officially launch the Jordan Pharmaceutical Center of Excellence (JPCoE), it announced in a press statement.

The Center, which is said to be the first of its kind both locally and regionally, would act as an open platform for communication between the pharmaceutical industry, government bodies and academic institutions. It will aim to promote continuous education and training in all fields of public health care, with a focus on the pharmaceutical industry and drug regulatory affairs.

The JPCoE will also create a database of all the equipment related to the drug industry available for hire in Jordan and identify the skills required for the validation and collection of information about experts in the industry and service providers in Jordan and abroad. It will be formulating partnerships with local and international universities and partners, which will lead to know-how transfers in order to enhance the competitiveness of the local and regional pharmaceutical industry in a globalized business environment, says the JAPM statement.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight